nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—ADRA1B—vas deferens—testicular cancer	0.0868	0.275	CbGeAlD
Olanzapine—CYP2C19—Ifosfamide—testicular cancer	0.081	0.136	CbGbCtD
Olanzapine—CYP2C9—Ifosfamide—testicular cancer	0.0674	0.113	CbGbCtD
Olanzapine—ABCB1—Dactinomycin—testicular cancer	0.0554	0.093	CbGbCtD
Olanzapine—HTR7—vas deferens—testicular cancer	0.0506	0.16	CbGeAlD
Olanzapine—ALB—Methotrexate—testicular cancer	0.0395	0.0663	CbGbCtD
Olanzapine—CYP3A4—Ifosfamide—testicular cancer	0.0392	0.0658	CbGbCtD
Olanzapine—CYP1A2—Etoposide—testicular cancer	0.0357	0.06	CbGbCtD
Olanzapine—ABCB1—Vinblastine—testicular cancer	0.0347	0.0582	CbGbCtD
Olanzapine—CYP2C9—Cisplatin—testicular cancer	0.0328	0.055	CbGbCtD
Olanzapine—CYP2D6—Vinblastine—testicular cancer	0.0327	0.0549	CbGbCtD
Olanzapine—ABCB1—Cisplatin—testicular cancer	0.0318	0.0534	CbGbCtD
Olanzapine—ABCB1—Etoposide—testicular cancer	0.0313	0.0525	CbGbCtD
Olanzapine—H1F0—semen—testicular cancer	0.0292	0.0925	CbGeAlD
Olanzapine—HTR7—vein—testicular cancer	0.0215	0.068	CbGeAlD
Olanzapine—ABCB1—Doxorubicin—testicular cancer	0.0213	0.0358	CbGbCtD
Olanzapine—CYP3A4—Vinblastine—testicular cancer	0.0208	0.0349	CbGbCtD
Olanzapine—ABCB1—Methotrexate—testicular cancer	0.0206	0.0347	CbGbCtD
Olanzapine—CYP2D6—Doxorubicin—testicular cancer	0.0201	0.0337	CbGbCtD
Olanzapine—CYP3A4—Etoposide—testicular cancer	0.0187	0.0314	CbGbCtD
Olanzapine—HTR2A—vein—testicular cancer	0.0134	0.0424	CbGeAlD
Olanzapine—CYP3A4—Doxorubicin—testicular cancer	0.0128	0.0214	CbGbCtD
Olanzapine—H1F0—embryo—testicular cancer	0.00659	0.0209	CbGeAlD
Olanzapine—DRD4—testis—testicular cancer	0.00632	0.02	CbGeAlD
Olanzapine—H1F0—seminal vesicle—testicular cancer	0.00619	0.0196	CbGeAlD
Olanzapine—HTR1E—female gonad—testicular cancer	0.00615	0.0195	CbGeAlD
Olanzapine—CHRM4—testis—testicular cancer	0.00478	0.0151	CbGeAlD
Olanzapine—DRD5—female gonad—testicular cancer	0.0047	0.0149	CbGeAlD
Olanzapine—H1F0—gonad—testicular cancer	0.00447	0.0142	CbGeAlD
Olanzapine—FMO3—testis—testicular cancer	0.00439	0.0139	CbGeAlD
Olanzapine—H1F0—female gonad—testicular cancer	0.00363	0.0115	CbGeAlD
Olanzapine—ADRA2C—seminal vesicle—testicular cancer	0.00351	0.0111	CbGeAlD
Olanzapine—H1F0—testis—testicular cancer	0.00322	0.0102	CbGeAlD
Olanzapine—FMO3—lymph node—testicular cancer	0.00319	0.0101	CbGeAlD
Olanzapine—HRH2—lymph node—testicular cancer	0.00284	0.00898	CbGeAlD
Olanzapine—ADRA2A—seminal vesicle—testicular cancer	0.0028	0.00887	CbGeAlD
Olanzapine—HTR7—gonad—testicular cancer	0.00276	0.00874	CbGeAlD
Olanzapine—HTR2A—embryo—testicular cancer	0.00254	0.00803	CbGeAlD
Olanzapine—ALB—testis—testicular cancer	0.00241	0.00764	CbGeAlD
Olanzapine—CHRM3—female gonad—testicular cancer	0.00236	0.00746	CbGeAlD
Olanzapine—H1F0—lymph node—testicular cancer	0.00234	0.0074	CbGeAlD
Olanzapine—CHRM3—testis—testicular cancer	0.00209	0.00662	CbGeAlD
Olanzapine—ADRA2C—female gonad—testicular cancer	0.00206	0.00653	CbGeAlD
Olanzapine—ADRA2A—gonad—testicular cancer	0.00202	0.00641	CbGeAlD
Olanzapine—ORM1—lymph node—testicular cancer	0.00199	0.00632	CbGeAlD
Olanzapine—HTR7—testis—testicular cancer	0.00199	0.0063	CbGeAlD
Olanzapine—DRD2—testis—testicular cancer	0.00188	0.00596	CbGeAlD
Olanzapine—ADRA2C—testis—testicular cancer	0.00183	0.00579	CbGeAlD
Olanzapine—ALB—lymph node—testicular cancer	0.00175	0.00554	CbGeAlD
Olanzapine—HTR2A—gonad—testicular cancer	0.00172	0.00545	CbGeAlD
Olanzapine—HTR2B—lymph node—testicular cancer	0.00168	0.00533	CbGeAlD
Olanzapine—HRH1—female gonad—testicular cancer	0.00167	0.0053	CbGeAlD
Olanzapine—ABCB1—embryo—testicular cancer	0.00166	0.00526	CbGeAlD
Olanzapine—ADRA2A—female gonad—testicular cancer	0.00164	0.00521	CbGeAlD
Olanzapine—ABCB1—seminal vesicle—testicular cancer	0.00156	0.00494	CbGeAlD
Olanzapine—HRH1—testis—testicular cancer	0.00148	0.0047	CbGeAlD
Olanzapine—ADRA2A—testis—testicular cancer	0.00146	0.00462	CbGeAlD
Olanzapine—ADRA2C—lymph node—testicular cancer	0.00133	0.0042	CbGeAlD
Olanzapine—CYP2D6—female gonad—testicular cancer	0.00127	0.00404	CbGeAlD
Olanzapine—HTR2A—testis—testicular cancer	0.00124	0.00393	CbGeAlD
Olanzapine—CYP2D6—testis—testicular cancer	0.00113	0.00358	CbGeAlD
Olanzapine—ABCB1—gonad—testicular cancer	0.00113	0.00357	CbGeAlD
Olanzapine—HRH1—lymph node—testicular cancer	0.00108	0.00341	CbGeAlD
Olanzapine—ADRA2A—lymph node—testicular cancer	0.00106	0.00335	CbGeAlD
Olanzapine—ABCB1—female gonad—testicular cancer	0.000916	0.0029	CbGeAlD
Olanzapine—ABCB1—testis—testicular cancer	0.000813	0.00257	CbGeAlD
Olanzapine—ABCB1—lymph node—testicular cancer	0.000589	0.00187	CbGeAlD
Olanzapine—CHRM4—GPCR downstream signaling—INSL3—testicular cancer	0.000316	0.00356	CbGpPWpGaD
Olanzapine—HTR2B—GPCR downstream signaling—INSL3—testicular cancer	0.000305	0.00344	CbGpPWpGaD
Olanzapine—HTR6—Signaling by GPCR—INSL3—testicular cancer	0.000304	0.00343	CbGpPWpGaD
Olanzapine—HTR7—Signaling by GPCR—INSL3—testicular cancer	0.000304	0.00342	CbGpPWpGaD
Olanzapine—CHRM5—GPCR downstream signaling—INSL3—testicular cancer	0.000302	0.00341	CbGpPWpGaD
Olanzapine—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	0.000302	0.0034	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—INSL3—testicular cancer	0.000302	0.0034	CbGpPWpGaD
Olanzapine—HTR1D—Signaling by GPCR—INSL3—testicular cancer	0.000302	0.0034	CbGpPWpGaD
Olanzapine—HTR1B—Signaling by GPCR—INSL3—testicular cancer	0.000295	0.00333	CbGpPWpGaD
Olanzapine—CHRM4—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	0.000291	0.00328	CbGpPWpGaD
Olanzapine—DRD4—Signaling by GPCR—INSL3—testicular cancer	0.000291	0.00328	CbGpPWpGaD
Olanzapine—DRD1—GPCR downstream signaling—INSL3—testicular cancer	0.000288	0.00325	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—INSL3—testicular cancer	0.000287	0.00323	CbGpPWpGaD
Olanzapine—DRD3—GPCR downstream signaling—INSL3—testicular cancer	0.000284	0.0032	CbGpPWpGaD
Olanzapine—CHRM5—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	0.000278	0.00314	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—INSL3—testicular cancer	0.000277	0.00313	CbGpPWpGaD
Olanzapine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	0.000277	0.00312	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—INSL3—testicular cancer	0.000275	0.00309	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—INSL3—testicular cancer	0.000263	0.00296	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—INSL3—testicular cancer	0.000262	0.00295	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—INSL3—testicular cancer	0.000258	0.00291	CbGpPWpGaD
Olanzapine—ADRA2B—GPCR downstream signaling—INSL3—testicular cancer	0.000257	0.00289	CbGpPWpGaD
Olanzapine—ALB—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000254	0.00286	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—INSL3—testicular cancer	0.000248	0.00279	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—INSL3—testicular cancer	0.000246	0.00278	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—INSL3—testicular cancer	0.00024	0.0027	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—INSL3—testicular cancer	0.000236	0.00266	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—INSL3—testicular cancer	0.000234	0.00264	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—INSL3—testicular cancer	0.000233	0.00263	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—INSL3—testicular cancer	0.000233	0.00262	CbGpPWpGaD
Olanzapine—CYP2C19—Biological oxidations—HPGDS—testicular cancer	0.000227	0.00256	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—INSL3—testicular cancer	0.000225	0.00254	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—INSL3—testicular cancer	0.000224	0.00252	CbGpPWpGaD
Olanzapine—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000223	0.00251	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—INSL3—testicular cancer	0.000218	0.00245	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—INSL3—testicular cancer	0.000217	0.00245	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—INSL3—testicular cancer	0.000214	0.00242	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—INSL3—testicular cancer	0.000214	0.00241	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—INSL3—testicular cancer	0.000214	0.00241	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—INSL3—testicular cancer	0.000213	0.0024	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—INSL3—testicular cancer	0.000212	0.00239	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—INSL3—testicular cancer	0.00021	0.00237	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—INSL3—testicular cancer	0.00021	0.00236	CbGpPWpGaD
Olanzapine—CYP2D6—Biological oxidations—HPGDS—testicular cancer	0.000208	0.00235	CbGpPWpGaD
Olanzapine—CYP2C9—Biological oxidations—HPGDS—testicular cancer	0.000207	0.00233	CbGpPWpGaD
Olanzapine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000203	0.00229	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—INSL3—testicular cancer	0.000197	0.00223	CbGpPWpGaD
Olanzapine—CHRM1—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	0.000196	0.00221	CbGpPWpGaD
Olanzapine—CHRM3—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	0.000195	0.0022	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—INSL3—testicular cancer	0.000195	0.00219	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—INSL3—testicular cancer	0.000194	0.00219	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—INSL3—testicular cancer	0.000194	0.00219	CbGpPWpGaD
Olanzapine—CHRM2—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	0.000193	0.00218	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—INSL3—testicular cancer	0.000193	0.00218	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—INSL3—testicular cancer	0.000193	0.00217	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—INSL3—testicular cancer	0.000191	0.00215	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—INSL3—testicular cancer	0.00019	0.00215	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—INSL3—testicular cancer	0.00018	0.00202	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—INSL3—testicular cancer	0.000179	0.00202	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—INSL3—testicular cancer	0.000178	0.00201	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—INSL3—testicular cancer	0.000177	0.00199	CbGpPWpGaD
Olanzapine—CYP1A2—Biological oxidations—HPGDS—testicular cancer	0.000177	0.00199	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—INSL3—testicular cancer	0.000174	0.00197	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—INSL3—testicular cancer	0.000172	0.00194	CbGpPWpGaD
Olanzapine—FMO3—Metabolism—HPGDS—testicular cancer	0.000171	0.00193	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—INSL3—testicular cancer	0.000169	0.00191	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—INSL3—testicular cancer	0.000164	0.00185	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—INSL3—testicular cancer	0.000162	0.00183	CbGpPWpGaD
Olanzapine—HTR5A—Signaling Pathways—H2AFZ—testicular cancer	0.000156	0.00176	CbGpPWpGaD
Olanzapine—HTR5A—Signaling Pathways—STK11—testicular cancer	0.000155	0.00175	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—INSL3—testicular cancer	0.000155	0.00174	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—INSL3—testicular cancer	0.000152	0.00172	CbGpPWpGaD
Olanzapine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000148	0.00167	CbGpPWpGaD
Olanzapine—HTR5A—Signaling Pathways—KITLG—testicular cancer	0.000143	0.00162	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—INSL3—testicular cancer	0.000138	0.00155	CbGpPWpGaD
Olanzapine—CYP3A4—Biological oxidations—HPGDS—testicular cancer	0.000136	0.00154	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—INSL3—testicular cancer	0.000133	0.0015	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—INSL3—testicular cancer	0.000132	0.00149	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—INSL3—testicular cancer	0.000129	0.00145	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—INSL3—testicular cancer	0.000127	0.00143	CbGpPWpGaD
Olanzapine—FMO3—Metabolism—STK11—testicular cancer	0.000124	0.0014	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—INSL3—testicular cancer	0.000117	0.00132	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—INSL3—testicular cancer	0.000115	0.00129	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—INSL3—testicular cancer	0.000115	0.00129	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—INSL3—testicular cancer	0.000114	0.00129	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—INSL3—testicular cancer	0.000114	0.00128	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—INSL3—testicular cancer	0.000113	0.00127	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—INSL3—testicular cancer	0.000112	0.00127	CbGpPWpGaD
Olanzapine—HTR5A—Signaling Pathways—FGFR3—testicular cancer	0.000107	0.0012	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—INSL3—testicular cancer	0.000104	0.00118	CbGpPWpGaD
Olanzapine—HTR5A—Signaling Pathways—KIT—testicular cancer	9.78e-05	0.0011	CbGpPWpGaD
Olanzapine—ALB—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	9.69e-05	0.00109	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—H2AFZ—testicular cancer	9.66e-05	0.00109	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—STK11—testicular cancer	9.61e-05	0.00108	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—KITLG—testicular cancer	8.89e-05	0.001	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	8.7e-05	0.000981	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—H2AFZ—testicular cancer	8.41e-05	0.000948	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—STK11—testicular cancer	8.36e-05	0.000943	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	7.94e-05	0.000895	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—KITLG—testicular cancer	7.74e-05	0.000872	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—H2AFZ—testicular cancer	7.49e-05	0.000845	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—STK11—testicular cancer	7.45e-05	0.00084	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—H2AFZ—testicular cancer	7.44e-05	0.000839	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—STK11—testicular cancer	7.4e-05	0.000834	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—KITLG—testicular cancer	6.89e-05	0.000777	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—KITLG—testicular cancer	6.85e-05	0.000772	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	6.78e-05	0.000765	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—HPGDS—testicular cancer	6.74e-05	0.000759	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—FGFR3—testicular cancer	6.61e-05	0.000745	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—KIT—testicular cancer	6.07e-05	0.000684	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—HPGDS—testicular cancer	5.96e-05	0.000672	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—FGFR3—testicular cancer	5.75e-05	0.000648	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—H2AFZ—testicular cancer	5.75e-05	0.000648	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—H2AFZ—testicular cancer	5.74e-05	0.000647	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—STK11—testicular cancer	5.71e-05	0.000644	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—STK11—testicular cancer	5.71e-05	0.000643	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—H2AFZ—testicular cancer	5.7e-05	0.000643	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—STK11—testicular cancer	5.67e-05	0.000639	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—H2AFZ—testicular cancer	5.58e-05	0.000629	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—STK11—testicular cancer	5.55e-05	0.000626	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—H2AFZ—testicular cancer	5.49e-05	0.000619	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—HPGDS—testicular cancer	5.47e-05	0.000617	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—STK11—testicular cancer	5.46e-05	0.000616	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—H2AFZ—testicular cancer	5.42e-05	0.000611	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—STK11—testicular cancer	5.39e-05	0.000608	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—KITLG—testicular cancer	5.29e-05	0.000596	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—KITLG—testicular cancer	5.28e-05	0.000595	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—KIT—testicular cancer	5.28e-05	0.000595	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—KITLG—testicular cancer	5.25e-05	0.000591	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—H2AFZ—testicular cancer	5.24e-05	0.000591	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—STK11—testicular cancer	5.21e-05	0.000588	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—H2AFZ—testicular cancer	5.19e-05	0.000585	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—STK11—testicular cancer	5.16e-05	0.000582	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—KITLG—testicular cancer	5.14e-05	0.000579	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—FGFR3—testicular cancer	5.12e-05	0.000577	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—FGFR3—testicular cancer	5.09e-05	0.000574	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—KITLG—testicular cancer	5.05e-05	0.00057	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—KITLG—testicular cancer	4.99e-05	0.000562	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—H2AFZ—testicular cancer	4.95e-05	0.000558	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—STK11—testicular cancer	4.92e-05	0.000554	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—STK11—testicular cancer	4.89e-05	0.000552	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—H2AFZ—testicular cancer	4.88e-05	0.00055	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—STK11—testicular cancer	4.85e-05	0.000547	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—KITLG—testicular cancer	4.83e-05	0.000544	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—KITLG—testicular cancer	4.78e-05	0.000538	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—KIT—testicular cancer	4.7e-05	0.00053	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—KIT—testicular cancer	4.67e-05	0.000527	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—KITLG—testicular cancer	4.55e-05	0.000513	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—KITLG—testicular cancer	4.49e-05	0.000506	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—H2AFZ—testicular cancer	4.41e-05	0.000497	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—STK11—testicular cancer	4.38e-05	0.000494	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—STK11—testicular cancer	4.33e-05	0.000488	CbGpPWpGaD
Olanzapine—ALB—Metabolism—HPGDS—testicular cancer	4.32e-05	0.000487	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—H2AFZ—testicular cancer	4.25e-05	0.00048	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—H2AFZ—testicular cancer	4.23e-05	0.000477	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—STK11—testicular cancer	4.23e-05	0.000477	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—STK11—testicular cancer	4.21e-05	0.000474	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—H2AFZ—testicular cancer	4.12e-05	0.000464	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—STK11—testicular cancer	4.09e-05	0.000461	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—KITLG—testicular cancer	4.05e-05	0.000457	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—H2AFZ—testicular cancer	4.05e-05	0.000457	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—STK11—testicular cancer	4.03e-05	0.000454	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—STK11—testicular cancer	3.97e-05	0.000448	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—FGFR3—testicular cancer	3.93e-05	0.000443	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—FGFR3—testicular cancer	3.92e-05	0.000442	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—KITLG—testicular cancer	3.91e-05	0.000441	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—FGFR3—testicular cancer	3.9e-05	0.00044	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—KITLG—testicular cancer	3.89e-05	0.000439	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—HPGDS—testicular cancer	3.88e-05	0.000437	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—FGFR3—testicular cancer	3.82e-05	0.00043	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—KITLG—testicular cancer	3.79e-05	0.000427	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—HPGDS—testicular cancer	3.78e-05	0.000427	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—FGFR3—testicular cancer	3.76e-05	0.000424	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—H2AFZ—testicular cancer	3.73e-05	0.000421	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—KITLG—testicular cancer	3.73e-05	0.00042	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—STK11—testicular cancer	3.71e-05	0.000419	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—FGFR3—testicular cancer	3.71e-05	0.000418	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—H2AFZ—testicular cancer	3.67e-05	0.000414	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—H2AFZ—testicular cancer	3.67e-05	0.000413	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—H2AFZ—testicular cancer	3.65e-05	0.000412	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—STK11—testicular cancer	3.65e-05	0.000412	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—STK11—testicular cancer	3.65e-05	0.000411	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—H2AFZ—testicular cancer	3.64e-05	0.000411	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—STK11—testicular cancer	3.63e-05	0.00041	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—STK11—testicular cancer	3.62e-05	0.000408	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—H2AFZ—testicular cancer	3.61e-05	0.000407	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—KIT—testicular cancer	3.61e-05	0.000407	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—KIT—testicular cancer	3.6e-05	0.000406	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—H2AFZ—testicular cancer	3.6e-05	0.000406	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—STK11—testicular cancer	3.59e-05	0.000404	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—FGFR3—testicular cancer	3.59e-05	0.000404	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—KIT—testicular cancer	3.58e-05	0.000404	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—STK11—testicular cancer	3.58e-05	0.000403	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—HPGDS—testicular cancer	3.56e-05	0.000402	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—FGFR3—testicular cancer	3.55e-05	0.0004	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—HPGDS—testicular cancer	3.53e-05	0.000398	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—KIT—testicular cancer	3.5e-05	0.000395	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—KIT—testicular cancer	3.45e-05	0.000389	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—KITLG—testicular cancer	3.44e-05	0.000387	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—KIT—testicular cancer	3.4e-05	0.000384	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—FGFR3—testicular cancer	3.38e-05	0.000381	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—KITLG—testicular cancer	3.38e-05	0.000381	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—KITLG—testicular cancer	3.37e-05	0.00038	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—KITLG—testicular cancer	3.36e-05	0.000379	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—KITLG—testicular cancer	3.35e-05	0.000378	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—H2AFZ—testicular cancer	3.34e-05	0.000377	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—FGFR3—testicular cancer	3.34e-05	0.000376	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—STK11—testicular cancer	3.32e-05	0.000375	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—KITLG—testicular cancer	3.32e-05	0.000374	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—KITLG—testicular cancer	3.31e-05	0.000373	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—KIT—testicular cancer	3.29e-05	0.000371	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—KIT—testicular cancer	3.26e-05	0.000367	CbGpPWpGaD
Olanzapine—ALB—Metabolism—STK11—testicular cancer	3.14e-05	0.000354	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—KIT—testicular cancer	3.1e-05	0.00035	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—KITLG—testicular cancer	3.08e-05	0.000347	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—KIT—testicular cancer	3.06e-05	0.000345	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—HPGDS—testicular cancer	3.02e-05	0.00034	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—FGFR3—testicular cancer	3.01e-05	0.00034	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—FGFR3—testicular cancer	2.91e-05	0.000328	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—FGFR3—testicular cancer	2.89e-05	0.000326	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—STK11—testicular cancer	2.82e-05	0.000317	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—FGFR3—testicular cancer	2.81e-05	0.000317	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—FGFR3—testicular cancer	2.77e-05	0.000312	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—KIT—testicular cancer	2.77e-05	0.000312	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—STK11—testicular cancer	2.75e-05	0.00031	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—KIT—testicular cancer	2.67e-05	0.000301	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—KIT—testicular cancer	2.66e-05	0.000299	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—STK11—testicular cancer	2.59e-05	0.000292	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—KIT—testicular cancer	2.58e-05	0.000291	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—STK11—testicular cancer	2.57e-05	0.000289	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—FGFR3—testicular cancer	2.55e-05	0.000288	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—KIT—testicular cancer	2.54e-05	0.000287	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—FGFR3—testicular cancer	2.51e-05	0.000283	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—FGFR3—testicular cancer	2.51e-05	0.000283	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—FGFR3—testicular cancer	2.5e-05	0.000282	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—FGFR3—testicular cancer	2.49e-05	0.000281	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—FGFR3—testicular cancer	2.47e-05	0.000278	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—FGFR3—testicular cancer	2.46e-05	0.000277	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—KIT—testicular cancer	2.34e-05	0.000264	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—HPGDS—testicular cancer	2.33e-05	0.000263	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—KIT—testicular cancer	2.31e-05	0.00026	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—KIT—testicular cancer	2.3e-05	0.000259	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—KIT—testicular cancer	2.29e-05	0.000259	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—KIT—testicular cancer	2.29e-05	0.000258	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—FGFR3—testicular cancer	2.29e-05	0.000258	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—KIT—testicular cancer	2.26e-05	0.000255	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—KIT—testicular cancer	2.26e-05	0.000255	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—STK11—testicular cancer	2.19e-05	0.000247	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—KIT—testicular cancer	2.1e-05	0.000237	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—STK11—testicular cancer	1.69e-05	0.000191	CbGpPWpGaD
